CRISPR Therapeutics AG CRSP

54.23 (1.47) (2.64%) as of 25 Sep
Market cap
$5.4B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
1,975.83 1,903.83 1,693.69 1,815.32 2,379.13 1,690.33 943.77 456.65 239.76 315.52
Receivables
— 25.00 200.00 11.00 0.31 0.14 0.10 0.09 2.63 3.16
Total current assets
1,985.67 1,937.13 1,908.08 1,853.03 2,417.51 1,716.62 987.55 466.40 248.39 320.19
Property, Plant, Equpment (Net)
115.85 134.09 151.95 163.63 137.58 42.16 31.33 18.50 18.86 21.03
Long-Term Investments
— — 1.97 53.13 17.00 17.00 5.00 3.00 3.00 3.00
Goodwill and Intangible Assets (Total)
— — 0.02 0.07 0.13 0.18 0.24 0.29 0.34 0.40
Long-term assets (Other)
32.00 27.35 13.57 16.28 22.20 18.14 6.14 3.83 3.76 3.35
Total non-current assets
279.57 304.90 321.49 390.03 334.36 111.35 79.21 22.62 22.96 24.77
Total Assets
2,265.24 2,242.03 2,229.57 2,243.06 2,751.88 1,827.97 1,066.75 489.02 271.35 344.96
Accounts Payable
11.14 14.71 38.15 27.43 14.82 9.09 5.94 5.07 1.64 4.57
Accrued Expenses
90.52 41.52 45.77 77.82 91.73 64.26 30.76 21.25 11.71 16.34
Current Revenue (Deferred)
15.77 3.85 4.11 — 1.01 2.34 0.96 0.10 — —
Other current liabilities
13.11 10.42 5.14 0.02 0.17 7.21 10.95 1.32 1.16 1.09
Total current liabilities
149.12 87.78 108.79 121.11 119.88 94.26 57.11 27.75 14.51 22.00
Long Term Debt (Total)
— — — 228.00 213.00 50.00 44.00 — — —
Non-current Revenue (Deferred)
— 12.32 14.01 12.32 12.32 12.00 11.78 57.78 56.93 77.65
Non-current Liabilities (Other)
6.14 3.44 0.96 5.97 7.34 19.41 14.40 11.30 12.08 12.47
Total non-current liabilities
194.31 222.17 237.98 246.47 232.53 69.47 70.22 69.08 69.00 90.12
Total liabilities
343.43 309.95 346.77 367.58 352.42 163.73 127.33 96.82 83.51 112.12
Additional Paid In Capital
3,861.52 3,293.56 2,878.16 2,734.84 2,598.11 2,235.68 1,162.35 682.25 312.02 288.74
Common Stock (Net)
3.09 2.70 2.50 2.44 2.39 2.28 1.85 1.58 1.24 1.22
Retained Earnings
(1,947.55) (1,365.95) (999.70) (846.09) (195.91) (573.58) (224.71) (291.57) (125.44) (57.08)
Treasury Stock
0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 — —
Common Equity (Total)
1,921.81 1,932.08 1,882.80 1,875.48 2,399.46 1,664.23 939.43 392.20 187.83 232.85
Shareholders Equity (Total)
1,921.81 1,932.08 1,882.80 1,875.48 2,399.46 1,664.23 939.43 392.20 187.83 232.85
Shareholders Equity and Liabilities (Total)
2,265.24 2,242.03 2,229.57 2,243.06 2,751.88 1,827.97 1,066.75 489.02 271.35 344.96
Shares (Common)
95.89 85.74 80.04 78.51 76.99 73.92 60.78 51.85 40.59 39.72
Shareholders Equity (Tangible)
1,921.81 1,932.08 1,882.79 1,875.41 2,399.34 1,664.05 939.19 391.91 187.49 232.45
Net Debt
(1,975.83) (1,903.83) (1,693.69) (1,587.32) (2,166.13) (1,640.33) (899.77) (456.65) (239.76) (315.52)
Total Debt
— — — 228.00 213.00 50.00 44.00 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates